Clinical trial
Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central…
NCT00131820 · International Vaccine Institute, Other · Completed
Key facts
| NCT number | NCT00131820 |
|---|---|
| Title | Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam |
| Official title | Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam. An Evaluation of Feasibility, Public Acceptability, Effectiveness and Cost-Effectiveness in Students |
| Lead sponsor | International Vaccine Institute, Other |
| Collaborators | National Institute of Hygiene and Epidemiology, Vietnam Hue Preventive Medicine Center, Vietnam Wellcome Trust University of Western Ontario, Canada GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Typhoid, Paratyphoid Fever |
| Intervention type | Biological |
| Interventions | Typhoid Vi vaccine, Hepatitis A (control) |
| Enrollment | 100,742 |
| Start date | Dec 1, 2001 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Aug 19, 2005 |
| Last update posted | Mar 13, 2008 |
| Countries | Vietnam |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: